From a library of genes that encode the antibodies, IMBiologics’s experienced research team screens out optimal antibody candidates that bind to a specific antigen of interest. A variety of antibodies against diverse diseases can be discovered from our naïve, synthetic, and immune antibody libraries. Through IMB’s unique antigen design with proven physiological properties, we maximize the opportunity to discover candidates with excellent drug-like properties and accelerated optimization processes.

We have fine-tuned an antibody screening and discovery platform based on phage display technology. With our platform, we can effectively select antibody candidates with optimal affinity and high specificity to antigen using a highly diverse antibody library.

Through skilled optimization strategies for candidate antibodies, we can reduce immunogenicity and improve specificity and affinity while maintaining superior efficacy.